Newt Myotubes Reenter the Cell Cycle by Phosphorylation of the Retinoblastoma Protein by Tanaka, Elly M. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/97/01/155/11 $2.00
The Journal of Cell Biology, Volume 136, Number 1, January 13, 1997 155–165 155
 
Newt Myotubes Reenter the Cell Cycle by
Phosphorylation of the Retinoblastoma Protein
 
Elly M. Tanaka,* Alexander A.F. Gann,*
 
§
 
 Phillip B. Gates,* and Jeremy P. Brockes*
 
‡
 
*Ludwig Institute for Cancer Research and 
 
‡
 
Department of Biochemistry and Molecular Biology, University College London, 
London W1P 8BT, United Kingdom; and 
 
§
 
Division of Biological Sciences, Lancaster University, Lancaster LA1 4YQ, United 
Kingdom
 
Abstract. 
 
Withdrawal from the cell cycle is an essential 
aspect of vertebrate muscle differentiation and requires 
the retinoblastoma (Rb) protein that inhibits expres-
sion of genes needed for cell cycle entry. It was shown 
recently that cultured myotubes derived from the 
Rb
 
2
 
/
 
2
 
mouse reenter the cell cycle after serum stimula-
tion (Schneider, J.W., W. Gu, L. Zhu, V. Mahdavi, and 
B. Nadal-Ginard. 1994. 
 
Science (Wash. DC).
 
 264:1467–
1471). In contrast with other vertebrates, adult urodele 
amphibians such as the newt can regenerate their limbs, 
a process involving cell cycle reentry and local reversal 
of differentiation. Here we show that myotubes formed 
in culture from newt limb cells are refractory to several 
growth factors, but they undergo S phase after serum 
stimulation and accumulate 4N nuclei. This response to 
serum is inhibited by contact with mononucleate cells. 
Despite the phenotypic parallel with Rb
 
2
 
/
 
2
 
 mouse myo-
tubes, Rb is expressed in the newt myotubes, and its 
phosphorylation via cyclin-dependent kinase 4/6 is re-
quired for cell cycle reentry. Thus, the postmitotic ar-
rest of urodele myotubes, although intact in certain re-
spects, can be undermined by a pathway that is inactive 
in other vertebrates. This may be important for the re-
generative ability of these animals.
 
T
 
erminal
 
 differentiation is associated with stable
withdrawal from the cell cycle. In mammalian sys-
tems, the return of mature, differentiated tissue to
an undifferentiated proliferating state is blocked since, in
many tissues, a return to the cell cycle could in principle
result in tumor formation or cell death. In contrast, in
urodele amphibians such as the adult newt, reversal of dif-
ferentiation is an integral part of their ability to regenerate
limbs and other structures (Brockes, 1994; Okada, 1991).
After amputation, epidermal cells from around the wound
surface migrate across it to form the wound epidermis.
The mesenchymal tissues beneath the wound epidermis
dedifferentiate to produce blastemal cells, the proliferat-
ing and undifferentiated cells that are the progenitors of the
new limb (Steen, 1968; Hay, 1959; Kintner and Brockes,
1984; Casimir et al., 1988). The capacity of newt myotubes
to dedifferentiate was demonstrated directly by purifying
myotubes formed from cultured newt limb cells, labeling
them by injection of a lineage tracer, and implanting them
beneath the wound epidermis of an early blastema (Lo et al.,
1993). 1–3 wk after implantation, labeled mononucleate
cells were found in the blastema, and their number in-
creased with time, indicating that the cells were proliferat-
ing. This experiment suggests that the local environment
of the blastema stimulates newt myotubes to reenter the
cell cycle and to reverse their differentiated state, thus
raising a number of issues concerning the identity of the
signals that stimulate dedifferentiation, as well as the un-
derlying mechanisms that allow newt cells but not their
mammalian counterparts to undergo this process.
Muscle has been a particularly informative system for
studying how cells maintain the nondividing, differenti-
ated state (Lassar et al., 1994; Olson, 1992). During differ-
entiation, myoblasts exit from the cell cycle in the G
 
1
 
phase and fuse to form a multinucleate syncitium that ex-
presses muscle-specific proteins and no longer responds to
mitogens. It has been shown that this insensitivity is not
caused solely by the down-regulation of cell surface recep-
tors, nor by an irreversible alteration in the capacity of the
nucleus to undergo DNA synthesis. The addition of mito-
gens such as EGF after cell cycle arrest but before recep-
tor down-regulation provokes various intracellular re-
sponses, but it does not stimulate cell division (Endo and
Nadal-Ginard, 1986; Olwin and Hauschka, 1988; Hu and
Olsen, 1990). On the other hand, if myotubes are trans-
fected with transforming viral proteins such as SV-40 large
T antigen or adenovirus E1A protein, the myotube nuclei
are induced to enter S phase (Endo and Nadal-Ginard,
1989; Iujvidin et al., 1990; Crescenzi et al., 1995).
These experiments with viral oncogenes suggest that the
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retinoblastoma (Rb)
 
1
 
 protein might have a critical role in
maintaining the postmitotic state because mutants of T an-
tigen that are unable to bind Rb do not promote cell cycle
reentry (Gu et al., 1993). This role of Rb has recently been
demonstrated directly: myoblast cells derived from the Rb
homozygous null (Rb
 
2
 
/
 
2
 
) mouse form myotubes that ex-
press muscle-specific proteins, but they reenter S phase in
response to serum (Schneider et al., 1994). The Rb protein
is a regulator of the G
 
1
 
-S restriction point of the cell cycle
and acts through the E2F family of transcription factors
that control the expression of several genes whose prod-
ucts are required for entry into S phase (Nevins, 1992;
LaThangue, 1994; Riley et al., 1995; Weinberg, 1995). Cur-
rent models indicate that Rb inhibits entry into S phase at
least in part by binding E2F and inhibiting transcriptional
activation. When cells sensitive to mitogen stimulation are
treated with serum, Rb is phosphorylated, thus losing its
ability to bind E2F and allowing activation of S-phase en-
try genes.
Mounting evidence suggests that there is a serum-respon-
sive pathway dedicated to the regulation of Rb phosphory-
lation in which the kinase complex cyclin-dependent kinase
(CDK) 4/6–cyclin D is the mitogen-responsive kinase of
Rb (Sherr, 1994; Hunter and Pines, 1994). This kinase ac-
tivity is regulated in part by the proteins of the INK4 class
of cyclin-dependent kinase inhibitors (CDIs) (Sherr and
Roberts, 1995), which specifically bind to and inhibit CDK4
and 6 (Serrano et al., 1993; Hannon and Beach, 1994;
Sheaff and Roberts, 1995; Koh et al., 1995). p16
 
INK4
 
 can
only inhibit entry to S phase or colony formation in cells
that express Rb, while inhibition of cyclin D1 is effective in
blocking S-phase entry only in cells containing Rb, thus es-
tablishing a functional link between CDK4 and Rb in cell
cycle control (Guan et al., 1994; Medema et al., 1995; Lukas
et al., 1994, 1995). In normal muscle, the CDIs p21 and the
p16
 
INK4
 
-related protein p18 are highly expressed (Parker
et al., 1995; Guan et al., 1994), with p21 being induced by
MyoD expression (Halevy et al., 1995; Guo et al., 1995).
These high levels of CDIs presumably inhibit the mitogen-
induced phosphorylation of Rb. In view of the plasticity of
newt cells, a possible difference between urodele and
other vertebrate cells may lie in the regulation of Rb func-
tion.
We are attempting to induce myotube dedifferentiation
in cultured newt cells where it may be possible to analyze
the underlying mechanism. This should provide insight
into the process of regeneration and also shed light on how
the differentiated state is regulated. Here we report that in
contrast with those of other vertebrates, cultured newt myo-
tubes formed from myogenic newt cells enter and traverse
S phase when stimulated with serum. In comparison to the
behavior of mammalian Rb
 
2
 
/
 
2
 
 myotubes (Schneider et al.,
1994), an attractive explanation for the response of newt
myotubes is that they lack Rb, but we show that these cells
express Rb and that phosphorylation of Rb is an endpoint
of the serum stimulation pathway. These results suggest
that the regulation of Rb phosphorylation is likely to be a
key difference that distinguishes the behavior of newt and
mammalian myotubes.
 
Materials and Methods
 
Cell Culture
 
Newt A1 cells were propagated as described (Ferretti and Brockes, 1988),
myogenesis was induced, and myotubes were purified as described earlier
(Lo et al., 1993). In brief, myotubes were formed by lowering the serum
concentration from 10 to 0.5%, purified after 4 d by brief trypsinization,
followed by neutralizing with media, sieving through a 100-
 
m
 
m mesh (Cell
MicroSieve; BioDesign Inc. of New York, Carmel, NY), and then sieving
through a 35-
 
m
 
m mesh. Myotubes were retained on this second sieve
while mononucleate cells passed through, and then washed off the sieve
into dishes precoated with 0.75% gelatin. For preparations requiring low-
est contamination of mononucleates, the myotubes were sieved onto 35-
 
m
 
m meshes twice before plating.
 
Bromodeoxyuridine Labeling and Immunofluorescence
 
To induce DNA synthesis, serum was raised to 10–20% at 1–2 d after puri-
fied myotubes were plated. After 4 d in serum, myotubes were labeled for
24 h with 1 
 
m
 
l/ml 5-bromo-2 deoxyuridine/5-fluoro-2-deoxyuridine using
the proliferation kit (Amersham Corp., Arlington Heights, IL) according
to instructions. Cells were fixed for 5 min with methanol, stained for bro-
modeoxyuridine (BrdU) as previously described (Barres et al., 1994), and
then stained for muscle-specific myosin using mAb against muscle-specific
myosin heavy chain (A4.1025), a kind gift of Dr. Simon Hughes (Randall
Institute, Kings College London, UK). FITC rabbit anti–mouse antibody
was used as a secondary antibody, and all antibodies were diluted in 10%
goat serum in PBS. For [
 
3
 
H]thymidine labeling, cultures were exposed to 1
 
m
 
Ci of [
 
3
 
H]thymidine per ml for 24 h, fixed with methanol, processed for an-
tibody staining, refixed with methanol, and then coated with photographic
emulsion (1:1, K-5; Ilford, Knutsford, Cheshire, UK) and developed after 2 d.
 
Determination of DNA Content
 
A more detailed account of the quantitative microscopy will be published
elsewhere. In brief, cells were fixed with methanol, washed with PBS,
treated with 2 N HCl for 5 min, washed with PBS, and stained with 10 
 
m
 
M
propidium iodide for 30 min. Propidium iodide was also included in the
mounting medium. The laser-scanning microscope (Biorad MRC-500;
Zeiss, Oberkochen, Germany) was used with a 
 
3
 
5 objective, with the dia-
phragm fully open, and aligned for a maximally even field of illumination.
Image analysis routines were used to threshold nuclei and to eliminate all
background so that the intensity of individual nuclei could be measured in
a semi-automated fashion. G
 
1
 
-, G
 
2
 
-, and S-phase peaks were determined
by using mononucleate cells that had been labeled for 2 h with BrdU. Nu-
clei with no BrdU labeling clustered around two peaks: a large peak rep-
resenting G
 
1
 
 cells with 2N DNA, and a small peak, twice as intense as the
first peak, representing G
 
2
 
 cells with 4N DNA. BrdU
 
1
 
 nuclei displayed in-
tensities between these peaks. 4N DNA was also confirmed by measuring
the intensity of mitotic cells.
 
Growth Factor Assay
 
Myotubes were purified and plated in low serum (0.5%) media. Purified
growth factors were added after 24 h, and cells were labeled 4 d later with
BrdU for 24 h. Assays were performed in triplicate and at least 300 nuclei
were counted per well. Mononucleate cells were plated at low density in
low serum (1%) media for 24 h, before growth factor addition, and BrdU
uptake was assayed 4 d later. Assays were performed in triplicate and at
least 500 cells were counted per well. The growth factors were a kind gift
of Dr. Mark Noble (Huntsman Cancer Institute, Salt Lake City, UT). Se-
rum was delipidated as described (Rothblat et al., 1976).
 
Contact Inhibition Experiments
 
To form myotubes at varying densities, 
 
z
 
1.3 
 
3
 
 10
 
5
 
, 2 
 
3
 
 10
 
5
 
, or 4 
 
3
 
 10
 
5
 
 A1
cells were plated onto 6-cm-diam tissue-culture dishes. After 24 h, myo-
genesis was induced by placing the cells in low serum media. After 5 d, se-
rum was added to 20%, and then BrdU uptake and staining were assayed
as described above.
 
1.
 
 Abbreviations used in this paper
 
: BrdU, bromodeoxyuridine; CDI, cy-
clin-dependent kinase inhibitor; CDK, cyclin-dependent kinase; CIP, calf
intestinal phosphatase; GST, glutathione-
 
S
 
-transferase; Rb, retinoblas-
toma. 
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To vary the number of mononucleate cells, myotubes were purified in
low serum media as described above and plated onto 3 
 
3
 
 3-cm-diam tis-
sue-culture dishes. After 24 h, mononucleate A1 cells ranging in number
from 
 
z
 
3 
 
3
 
 10
 
4
 
 to 26 
 
3
 
 10
 
4
 
 were plated onto the plates in low serum me-
dia. After 48 h, serum was added to 20%, and then BrdU uptake and
staining were assayed as described above.
 
Tilt Experiment. 
 
Myotubes were purified in low serum media as de-
scribed above and plated onto two 6-cm-diam tissue-culture dishes. After
24 h, 
 
z
 
2.5 
 
3
 
 10
 
5
 
 A1 cells were added, and the plates were tilted to allow
cells to settle in a gradient of densities on the plate. After 48 h, serum was
added to 20%, and then BrdU uptake and staining were assayed as de-
scribed above.
 
Rb Cloning and RNase Protection
 
Degenerate oligonucleotides to the E1A binding region of Rb were used
in a PCR reaction to obtain a 570-bp fragment from a 
 
l
 
ZAP retinoic acid–
treated newt limb blastema cDNA library. This was used to probe a 
 
l
 
gt11
limb blastema cDNA library (Brown and Brockes, 1991) from which two
positive clones were isolated and sequenced. Both contained the 3
 
9
 
 stop
codon but lacked 600 bp of 5
 
9
 
 sequence, which was obtained from the
 
l
 
ZAP library by PCR using antisense oligonucleotides to sequences from
within the gt11 clones together with 
 
l
 
ZAP primers. The amplified frag-
ment was cloned in pBSK (Stratagene, La Jolla, CA). Total RNA was pre-
pared and RNase protection was performed essentially as described
(Brown and Brockes, 1991). Total RNA (10 
 
m
 
g) was annealed with a 330-
bp probe from the E1A binding region to give the predicted 280-bp pro-
tected fragment. The gel was exposed for 2–3 d at 
 
2
 
70
 
8
 
C.
 
Generation of Affinity-purified Polyclonal
Antibody SK70
 
A glutathione-S-transferase (GST) fusion protein containing the newt Rb
sequence from amino acids 269–447 was produced in bacteria, solubilized
using sarcosyl (Frangioni and Neel, 1993), and purified using glutathione–
Sepharose (Pharmacia, Uppsala, Sweden) followed by thrombin cleavage.
Antibodies against the purified protein were produced in rabbits by Euro-
gentec (Seraing, Belgium). For affinity purification, IgG was precipitated
from serum with ammonium sulfate and passed through a GST-myf-5 af-
finity column to remove anti-GST antibodies, then passed over an Affigel
matrix coupled to the newt Rb fragment, and subsequently washed and
eluted with glycine/HCl.
 
Immunoprecipitation and Western Blotting
 
Immunoprecipitation was performed essentially as described in Hu et al.
(1991). Briefly, in experiments with mononucleate cells, 
 
z
 
800,000 cells
were rinsed with PBS and lysed for 30 min on ice with 2 ml of lysis buffer.
Cellular debris was removed by centrifugation for 1 min at 10,000 
 
g
 
. In ini-
tial experiments, extracts were precleared with rabbit serum and fixed 
 
Sta-
phylococcus aureus
 
 as described (Harlow and Lane, 1988), but this was
later found to be unnecessary. For immunoprecipitation with rabbit anti-
body, 1 ml of lysate was incubated with 1 
 
m
 
l SK70 on ice for 1 h, and then
incubated 1 h with 10 
 
m
 
l protein A–Sepharose beads (Pharmacia). For im-
munoprecipitation with XZ56 (Hu et al., 1991), 1 ml of lysate was incu-
bated for 2 h with 10 
 
m
 
l protein A–Sepharose beads that had been cross-
linked with XZ56 antibody, using dimethyl pimelimidate as described in
Harlow and Lane (1988). Phosphatase treatment of immunoprecipitates
was essentially as described in Ludlow et al. (1989). Immunoprecipitated
beads were washed twice with wash buffer (155 mM NaCl, 20 mM Tris,
pH 8, 5 mM EDTA, 0.05% NP-40, 0.02% NaN
 
3
 
), and then washed once
with CIP buffer (100 mM Tris, pH 8, 100 mM NaCl, 5 mM MgCl
 
2
 
). Beads
were incubated with 40 U calf intestinal phosphatase (Boehringer Mann-
heim Biochemicals, Indianapolis, IN) per 60 
 
m
 
l buffer plus 2 mM PMSF,
20 
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml leupeptin with or without phosphatase
inhibitors (15 mM NaF, 150 
 
m
 
M sodium orthovanadate) for 15 min at
37
 
8
 
C, and then washed twice in wash buffer and solubilized in Laemmli
sample buffer for 10 min at 80
 
8
 
C.
For detection of Rb in myotubes, myotubes were purified from 17 
 
3
 
100-mm dishes plated onto two 100-mm dishes and kept in 0.5% serum
(low serum) or 20% serum (high serum) for 4 d. One 100-mm plate of pu-
rified myotubes that contained 
 
z
 
50,000 myotube nuclei, with 
 
,
 
10%
mononucleate contamination, was lysed in 1 ml buffer and centrifuged as
above. Samples were incubated with 1 
 
m
 
l SK70 for 1 h, then with 10 
 
m
 
l
XZ56 for 1 h with rocking, and further with 10 
 
m
 
l protein A–Sepharose for
1 h. The samples were then washed three times with wash buffer before
solubilization in Laemmli sample buffer for 10 min at 80
 
8
 
C. Samples were
resolved on 7% SDS polyacrylamide gels, Western blotted onto nitrocel-
lulose, blocked in 1% dried milk in TBS/0.1% Triton X-100 for 30 min,
and then probed with SK70 at a 1:200 dilution followed by HRP-conju-
gated donkey anti–rabbit secondary antibody (Amersham Corp.) and en-
hanced chemiluminescence (ECL; Amersham Corp.).
 
D
 
34 and p16 Expression
 
The p16 expression plasmid (pcDNA3WTp16) was a kind gift of Drs.
David Parry and Gordon Peters (Imperial Cancer Research Fund, Lon-
don, UK). For p16 and control microinjections, plasmid (0.2, 0.6, or 1.0
 
m
 
g/ml) was microinjected into myotube nuclei using an Eppendorf micro-
injection apparatus at 24 h after purified myotubes were plated in low se-
rum media. Microinjection into a single nucleus per myotube was suffi-
cient to generate expression of protein that spread throughout the cell
cytoplasm. Myotubes were transferred to medium with 20% serum 24 h
after injection, and BrdU uptake was assayed after 4 d as described above.
The p16 protein was detected using mAb DCS-50.2 (a kind gift of Dr.
Gordon Peters) at 2.6 
 
m
 
g/ml. In parallel control experiments, 0.2 or 1 mg/
ml alkaline phosphatase expression plasmid (pCAP) (Schilthuis et al.,
1993) was microinjected and BrdU uptake was assayed as above. Alka-
line phosphatase was visualized with 5-bromo-4-chloro-3-indoyl-phos-
phate, and BrdU was detected using an HRP-conjugated secondary anti-
body.
The 
 
D
 
34 expression plasmid was a kind gift of Dr. N. Jones (Imperial
Cancer Research Fund, London, UK), and Rb plasmid pJ3WHRbc was a
kind gift of Dr. P. Jat (Ludwig Institute, London, UK). The DNA was mi-
croinjected at 0.5 mg/ml at 48 h after plating, and cells were placed in high
serum media after an additional 48 h. [
 
3
 
H]Thymidine uptake was assayed
as described above. This protocol, which uses longer times for plating and
expression as compared with the p16 experiments, was adopted after the
p16 experiments to optimize the number of myotubes obtained. Newt myo-
tubes frequently require 48 h to attach fully, so this latter protocol allowed
more cells to be injected. Rb protein expression was detected using mAb
G3-245 (Pharmingen, San Diego, CA).
 
Results
 
Cultured Newt Myotubes Undergo S Phase in Response 
to Serum
 
In earlier studies it was shown that A1 newt limb cells stop
dividing and fuse to form myotubes in low (0.5%) serum
medium (Lo et al., 1993). The myotubes contract in re-
sponse to mechanical stimulation and express markers of
differentiation such as muscle-specific myosin heavy chain
(Fig. 1 
 
A
 
). They could be purified from residual mononu-
cleate cells using 35-
 
m
 
m cell sieves as described previously
(Lo et al., 1993). Such preparations result in 
 
,
 
10% con-
tamination by mononucleates as assayed by counting nu-
clei. When purified myotubes were exposed to medium
containing 10% FCS, they responded by synthesizing
DNA as assayed by incorporation of BrdU. Fig. 1 shows
two myotubes, both of which show positive immunostain-
ing in their cytoplasm for muscle-specific myosin. Hoechst
staining (Fig. 1 
 
A
 
) shows that each myotube contains mul-
tiple nuclei; those in the myotube on the right have incor-
porated BrdU (Fig. 1 
 
B
 
). In the preparation shown in Fig. 1,
additional mononucleate cells were plated with the puri-
fied myotubes to illustrate that the BrdU incorporation in
the myotubes is comparable to that in normal, proliferat-
ing cells and is unlikely to be due to the activation of DNA
repair mechanisms.
The myotubes entered S phase somewhat asynchro-
nously, starting 2 d after serum addition and with the high-
est number of nuclei incorporating BrdU at 4 d. Despite 
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this delay, we found that serum stimulation for as little as 8 h
was sufficient to generate the response. Furthermore, the
uptake of BrdU within a myotube tended to include either
all the nuclei or none at all. A dose response showed that
the myotube response saturated at 
 
z
 
10% serum (Fig. 1 
 
C
 
).
In this experiment, 25% of nuclei incorporated BrdU in a
24-h period on day 3, but overall at least 75% of the cells
undergo DNA synthesis after stimulation. Such a response
was not found in mouse myotubes. Myotubes formed from
the myoblast cell line, C2C12, were purified in a similar
way, and BrdU incorporation was assayed up to 72 h after
serum stimulation. Cell cycle reentry was not seen in these
myotubes even after examination of several thousand nuclei.
To eliminate the possibility that the newt myotubes un-
dergo an aberrant DNA synthesis or activate DNA repair,
we determined if the nuclei traverse an S phase of normal
duration by executing the protocol outlined in Fig. 2 
 
A.
 
Multiple plates of myotubes were labeled with an 8-h pulse
Figure 1. Serum stimulates newt myotubes to enter S phase. (A) The two A1 myotubes are stained with muscle-specific myosin (green)
and Hoechst to stain DNA (blue). (B) The same myotubes showing muscle-specific myosin (green) and BrdU-positive nuclei (yellow).
The myotube on the upper right has incorporated BrdU during a 24-h pulse given on day 4 after serum stimulation; the myotube on the
lower left is negative for BrdU. (C, facing page) The graph shows the percentage of myotubes taking up BrdU at various concentrations
of serum. Cells were labeled with BrdU for 24 h at 3 d after addition of serum. Bar, 100 mm. 
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light bars
 
). It is clear that the BrdU-positive nuclei have
fluorescence emissions that lie between the 2N and 4N
peaks. 8% of the serum-starved cells labeled with BrdU
(data not shown).
We compared the distributions of fluorescence intensity
of myotube nuclei maintained in low serum vs those that
had been stimulated with serum for 9 d. To serve as an in-
ternal standard for 2N/4N peaks, mononucleate cells were
seeded on the same plate as the myotubes in high serum
media (Fig. 3 
 
B
 
). In low serum almost all myotube nuclei
had intensities corresponding to 2N DNA (Fig. 3 
 
B
 
, 
 
dark
bars
 
), as would be expected for nuclei in G
 
0
 
/G
 
1
 
. In marked
contrast, a significant number of nuclei in myotubes stimu-
lated with serum had intensities around 4N (
 
hatched bars
 
).
This confirms that the nuclei stimulated to undergo DNA
synthesis were arrested in G
 
2
 
.
 
Newt Myotubes Are Refractory to Several Common 
Polypeptide Growth Factors
 
Myoblasts divide in response to mitogens such as bFGF
Figure 2. Myotube nuclei complete S phase in response to serum.
(A). An outline of the experimental design to determine the du-
ration of S phase in the myotubes (see text for details). Purified
myotubes were labeled with an 8-h pulse of [3H]thymidine 2 d af-
ter addition of 20% serum. At various times after this first pulse,
samples were labeled with BrdU for 24 h (lower arrows) and
fixed. (B) The number of myotubes positive for [3H]thymidine is
compared with those positive for both [3H]thymidine and BrdU
as the time between the [3H]thymidine and BrdU pulses in-
creases. The x axis denotes the time as shown in A. (Open squares)
Number of myotubes containing only [3H]thymidine–labeled nu-
clei. These cells had begun S phase at the time of the [3H]thymi-
dine pulse, but they had completed it before labeling with BrdU.
(Closed diamonds) Number of myotubes containing nuclei posi-
tive for both [3H]thymidine and BrdU. These cells had continued
to synthesize DNA from the time of the [3H]thymidine pulse to
the time of the relevant BrdU pulse. Note that the majority of nu-
clei that had begun S phase on day 2 (when [3H]thymidine was
given) had completed it by day 5.
of [3H]thymidine 2 d after serum addition, thus identifying
those myotubes that had begun to synthesise DNA at this
point. At varying times after the exposure to [3H]thymi-
dine, individual plates were labeled with BrdU for 24 h
and then fixed and processed for immunohistochemistry
and autoradiography. Nuclei that were [3H]thymidine1
and BrdU1 were those that had started DNA synthesis on
day 2 and were still undergoing DNA synthesis at the time
of the BrdU labeling. Nuclei that were [3H]thymidine1 but
BrdU2 were those that had started DNA synthesis on day 2,
but had completed it before the second labeling. As seen
in Fig. 2 B, of the cells given the BrdU pulse immediately
after the [3H]thymidine, almost all [3H]thymidine1 nuclei
were also BrdU1, but of those labeled with BrdU 2 d af-
ter the [3H]thymidine pulse (4 d after serum), the number
of [3H]thymidine1BrdU1 cells had decreased, and it was
only 1% by 4 d after the [3H]thymidine pulse (6 d after se-
rum). This indicates that S phase lasts z48–72 h in the myo-
tube nuclei, which is similar to the length of S phase in
mononucleate newt cells (Wallace and Maden, 1976). Sig-
nificantly, this experiment also shows that the total num-
ber of [3H]thymidine1 cells present remained relatively
constant throughout the experiment, demonstrating that
there was little cell death as a consequence of reentry.
There was no evidence of mitotic figures in the newt
myotubes, even at 10 d after serum stimulation, suggesting
that the nuclei arrest in G2 phase. To confirm this finding,
we determined the DNA content of myotube nuclei by fix-
ing and staining the cells with propidium iodide and then
measuring the fluorescence emission of the nuclei by scan-
ning microscopy (see Materials and Methods). We vali-
dated the method by comparing the DNA content of serum-
starved mononucleate cells where the majority of nuclei
should be 2N (Fig. 3 A, dark bars, asterisk), with mononu-
cleate cells grown in 10% serum where at least 50% of the
cells should have DNA content between 2N and 4N (Fig.
3 A, hatched bars). The value for 4N DNA was confirmed
by measuring the intensity of mitotic nuclei (double aster-
isk). Before fixation, the cells were labeled for 2 h with
BrdU to determine the DNA content of the subset of cells
that were in S phase or had just completed it (Fig. 3 A,The Journal of Cell Biology, Volume 136, 1997 160
and EGF, and thus it was important to determine if the re-
turn of newt myotubes to the cell cycle was due to the re-
tention of sensitivity to such growth factors. A number of
polypeptide growth factors including PDGF, EGF, IGF,
and FGF were tested (Table I), and although they each
stimulated division of mononucleate newt A1 cells, none
elicited cell cycle reentry of the newt myotubes. These fac-
tors were also assayed in the presence of 5% bovine
plasma and no response was observed. It is thus apparent
that the urodele cells are as refractory to these growth fac-
tors as their mammalian counterparts (Olson, 1992).
Cell Cycle Reentry Is Dependent on Cell Density
Unpurified newt myotubes formed from dense cultures of
myoblasts did not consistently respond to serum. This sug-
gested that cell cycle reentry is inhibited by contact with
other cells, and this possibility was further investigated.
First, we examined the reponse of myotubes formed from
varying densities (ranging threefold) of myoblasts. With-
out purification, myotubes formed in dense cultures of myo-
blasts were unresponsive to serum, whereas those formed
in sparse cultures did respond (Table II A). To determine
if purified myotubes could also be regulated by cell den-
sity, we examined the effect of adding back A1 cells to pu-
rified myotubes. 24 h after plating purified newt myotubes,
mononucleate cells were added at varying densities and cul-
tured in low serum for 48 h before addition of serum. Myo-
tubes surrounded by a subconfluent population of mono-
nucleate cells responded to serum as well as purified
myotubes, while myotubes surrounded by a confluent pop-
ulation of cells were inhibited from cell cycle reentry (Ta-
ble II B). This inhibition of BrdU uptake into myotubes is
significantly greater than the effect of density on the
mononucleate A1 cells that appear to be relatively insensi-
tive to contact inhibition. To determine if inhibition re-
flected direct cell–cell contact rather than the action of a
soluble factor released by the mononucleate cells, we per-
Figure 3. Nuclei with 4N DNA content accumulate in serum-
stimulated myotubes. (A) A histogram of fluorescence intensity
of propidium iodide–stained nuclei from mononucleate A1 cells.
Intensity profiles from serum-starved cells (dark bars) and cy-
cling cells maintained in high serum (hatched bars) were com-
pared. (Asterisks) Intensities of 2N (*) and 4N (**) nuclei (see
text and Materials and Methods). In addition, the profile gener-
ated by the subset of cells in high serum that had incorporated
BrdU in a 2-h labeling is shown (light bars). Intensities fall be-
tween the 2N and 4N peaks. (B) The intensity profile of mononu-
cleate cells plated with the myotubes in high serum shown in Fig.
3 C. These cells provided an internal standard to verify the inten-
sities corresponding to 2N (*) and 4N DNA (**). (C) The DNA
content of individual nuclei was measured in myotubes main-
tained in low serum vs those stimulated with high serum. (Black
bars) DNA content of nuclei from myotubes kept in 0.5% serum
medum for 9 d. Most nuclei have 2N DNA content, and very few
have 4N, consistent with withdrawal from the cell cycle in G1.
(Hatched bars) DNA content of nuclei from myotubes kept in
10% serum medum for 9 d. A substantial proportion of cells have
nuclei of 4N DNA content, consistent with passage through S
phase and arrest before mitosis.
Table I. Effects of Serum and Purified Factors on Myotube 
Entry into S Phase
Substance Myotubes Mononucleates
bFGF 21
PDGF 21
EGF 21
IFG-1 21
TGFB 2 *
TNFa2 ND
Delipidated serum 11
Dialyzed serum (MWCO 6,000–8,000) 11
Boiled serum 2 ND
Gel filtration (Superose 12) 150–300 kD ND
Fibronectin 2 ND
Vitronectin 2 ND
Laminin 2 ND
Pretreatment of culture dish with FCS 2 ND
Growth factors were added at the following concentrations: 10 ng/ml bFGF, 10 ng/ml
PDGF, 50 ng/ml EGF, 100 ng/ml IGF, 10 ng/ml TGFB, 200 and 2,000 U/ml TNFa. In
assays of growth stimulation in mononucleate A1 cells, (1) represents a greater than
fivefold increase in the number of BrdU1 cells as compared with cells growing in me-
dia containing 1% serum. In assays on myotubes, (2) represents ,0.2% BrdU1 nuclei
in an assay where 10% serum induced 30% BrdU1 nuclei. (*) TGFB induced growth
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formed the following experiment. After plating purified
myotubes in a uniform distribution, mononucleate cells
were attached in a gradient of density across the plate by
tilting it. In the region of the plate where mononucleate
cells were sparse, myotubes responded to serum, whereas,
on the opposite side of the plate where cells were dense,
myotubes were completely inhibited from responding (Ta-
ble II C). This result provides strong evidence against a
diffusible inhibitor and in favor of regulation by local cell
contact.
Newt Myotubes Express Rb
As a result of the similarity of newt myotubes and murine
Rb2/2 myotubes in their response to serum (Schneider et al.,
1994), we determined if Rb or an Rb-like gene is ex-
pressed in the urodele cells. Full-length cDNA of newt Rb
was isolated and sequenced as described in Materials and
Methods. It encodes a protein with a predicted molecular
mass of 103 kD (see Fig. 5) that is 62% identical to mouse
Rb (Bernards et al., 1989) and 59% identical to Xenopus
(Destree et al., 1992). It is interesting that the predicted
newt protein, like Xenopus Rb, lacks the proline-rich se-
quences found at the NH2 terminus of the mouse se-
quence.
RNase protection analysis revealed that Rb is tran-
scribed in all of the tissues assayed, including A1 myo-
blasts and myotubes as well as normal limb and blastemal
tissue (Fig. 4), and analysis by Northern blot revealed two
transcripts of z4 and 6 kb in normal limb tissue (not
shown). As discussed further below, immunological detec-
tion of Rb indicated that the protein is expressed in the
Table II. Cell Cycle Reentry Is Sensitive to Cell Density
High Density Medium Density Low Density
Myotube Mononucleate Myotube Mononucleate Myotube Mononucleate
A. Myotubes fused 1/1,273 91/290 6/1,352 124/302 354/1,284 126/276
at different densities {0.1%} {31%} {0.4%} {41%} {28%} {46%}
B. Added mononucleates 2/804 89/485 96/546 148/300 102/501
{0.2%} {18%} {18%} {49%} {20%}
C. Tilt 1/1,527 ND 56/606 ND
{0.06%} {9%}
Myotubes cultured with varying numbers of mononucleate cells show varying response to serum. (A) Unpurified myotubes formed from varying densities of myoblasts. High den-
sity represented starting cell densities of 140 cells per mm2; medium density represented 70 cells per mm2; and low density represented 46 cells per mm2. (B) Varying numbers of
mononucleate cells were plated onto plates of myotubes. Numbers represent the number of BrdU1 nuclei per total number of nuclei in myotubes or the mononucleate cells. High
density corresponded to z370 cells per mm2; medium density corresponded to 110 cells per mm2; and low density corresponded to no added cells. (C) Mononucleate cells were
plated in a density gradient across a single plate of uniformly distributed myotubes. High and low density represent the counts for nuclei in myotubes in two extreme sectors of the
plate, which were each 10% of the area of the plate.
Figure 4. Sequence and ex-
pression of newt Rb. (A) The
amino acid sequence of the
newt Rb protein, predicted
from the cDNA sequence, as
compared with that of
mouse. (-) Positions where
identical residues are found.
(.) Positions at which gaps
have been introduced to op-
timize the alignment. As with
Xenopus Rb, newt Rb lacks
the distinct NH2-terminal
proline-rich sequence found
in the mouse sequence. The
predicted size of the encoded
protein is 103 kD, compared
with 105 kD for mouse and
103 kD for Xenopus. The
overall identity with mouse is
62%, and with Xenopus 59%.
These sequence data are
available under the EMBL/
GenBank/DDBJ accession
number Y09226. (B) RNase
protection assay demonstrat-
ing that newt Rb is expressed
in the A1 cells and myotubes,
as well as in normal limb and
limb blastema tissue.The Journal of Cell Biology, Volume 136, 1997 162
myotubes (Fig. 5 B). It is clear, therefore, that the myotubes
are not Rb negative.
Phosphorylation of Rb Is Required for Cell
Cycle Reentry
It was important to determine if cell cycle reentry of the
newt myotubes occurred via the phosphorylation of Rb.
To this end, we first asked whether expression of the CDI,
p16, which specifically inhibits the CDK4/6 class of ki-
nases, is able to inhibit the serum response. This would im-
plicate Rb phosphorylation in cell cycle reentry, and it would
indicate that the phosphorylation of Rb occurs via activa-
tion of CDK4/6. When human p16 was expressed in the
newt myotubes, it completely inhibited uptake of BrdU
(Table III). Control injections with plasmids expressing al-
kaline phosphatase had normal levels of DNA synthesis.
To test more directly whether phosphorylation of Rb
was required for the serum response, we determined if ex-
pression of the D34 Rb mutant (Hamel et al., 1992), in
which all eight of the CDK consensus phosphorylation
sites have been mutated, blocked entry into S phase. This
mutant should compete with endogenous Rb and therefore
inhibit any events that require Rb phosphorylation. Myo-
tubes maintained in low serum media were transfected by
microinjection with a plasmid encoding either the D34 Rb
or wild-type Rb as a control. 2 d after microinjection, myo-
tubes were transferred to high serum, and, after 4 d, myo-
tubes were assayed for [3H]thymidine incorporation, with
Rb expression detected by immunofluorescence using
mAb G3-245. As seen in Table IV, expression of D34 Rb
resulted in 88% inhibition of DNA synthesis as compared
with only 30% inhibition by wild-type Rb.
The Phosphorylation of Newt Rb during
Serum Stimulation
We next examined the phosphorylation state of endoge-
nous Rb in the newt myotubes. In mammalian cells such as
quiescent fibroblasts and resting lymphocytes, Rb is hypo-
phosphorylated and becomes phosphorylated when the
cells are stimulated to enter S phase. This transition can be
detected by a mobility shift on SDS gels. When an affinity-
Figure 5. (A) The SK70 antibody recognizes phos-
phorylated Rb. Affinity-purified polyclonal rabbit
antibody (SK70) prepared against newt Rb was
used to immunoprecipitate and detect Rb by
Western blotting from mononucleate A1 extracts
(lanes  1–3). Immunoprecipitates were either
treated with calf intestinal phosphatase (CIP) plus
phosphatase inhibitors, NaF and orthovanadate
(lane  1); treated with CIP with no inhibitors (lane
2); or directly prepared for electrophoresis without
any phosphatase treatment (lane 3). Separate ex-
tracts were immunoprecipitated with XZ56, an Ab
against human Rb, and probed on the same West-
ern blot using SK70 (lanes 4–6). Immunoprecipi-
tates were either treated with CIP plus phos-
phatase inhibitors (lane 4) or CIP with no inhibi-
tors (lane 5) or directly prepared for electrophoresis
(lane 6). The phosphatase-treated immunoprecipi-
tated protein (lane 5) migrates at precisely the
same molecular weight as the phosphatase-treated
protein that is immunoprecipitated by SK70 (lane
2). (B) Profile of Rb phosphorylation in purified
myotubes maintained in low vs high serum. Ex-
tracts made from highly purified myotubes main-
tained in low (lane 1) and high serum (lane 2) me-
dia and from mononucleate cells (lane 3) were
immunoprecipitated simultaneously with SK70 and XZ56 to detect all forms of Rb and Western blotted using SK70. Myotubes in low
serum media have withdrawn from the cell cycle and contain only the nonphosphorylated form of Rb (lane 1). Myotubes stimulated
with high serum media to reenter the cell cycle contain phosphorylated forms of Rb (lane 2). This profile is similar to the profile of Rb
migration found in proliferating mononucleate cells (lane 3).
Table III. Expression of Human p16 in Myotubes Inhibits 
Reentry to the Cell Cycle
BrdU1 nuclei
Total nuclei Percentage
%
p16 0 0
506
Uninjected 252 33
771
Alkaline phosphatase 78 49
158
Uninjected 271 47
572
Separate plates of myotubes were microinjected with an expression plasmid encoding
either the CDK inhibitor p16 or, as a control, human placental alkaline phosphatase.
The myotubes were stimulated with serum, and entry into S phase was measured as
described. The top panel shows the proportion of nuclei in p16-positive myotubes that
took up BrdU compared with the equivalent proportion for uninjected myotubes on
the same plates. The bottom panel shows the equivalent proportions for the nuclei in
alkaline phosphatase–positive myotubes compared with uninjected control myotubes
on the same plates. A block of entry into S phase by p16 is evident, whereas the alka-
line phosphatase control has no effect. This shows the results of a single experiment in
which DNAs were injected at 0.2 mg/ml. In other experiments, p16 had a similar effect
when injected at 0.6 or 1 mg/ml, whereas alkaline phosphatase had no effect at 1 mg/ml.Tanaka et al. Myotubes Reenter the Cell Cycle 163
purified polyclonal rabbit antibody (SK70) prepared
against a portion of the pocket region of newt Rb was used
to analyze Rb in extracts of proliferating mononuclate A1
cells by immunoprecipitation and subsequent Western
blotting, a series of bands spanning 110–116 kD was spe-
cifically recognized (Fig. 5 A, lane 3). Treatment of the
immunoprecipitate with calf intestinal phosphatase caused
the protein to migrate as a single 110-kD band (Fig. 5 A,
lane 2), a change blocked by inclusion of phosphatase in-
hibitors (Fig. 5 A, lane 1). The identity of these bands as Rb
was further confirmed by immunoprecipitating extracts of
mononucleate cells with an mAb against human Rb
(XZ56; Hu et al., 1991), which is known to cross-react with
Xenopus Rb, and then by Western blotting with SK70
(Fig. 5 A, lane 6). In this case, a doublet at 110 kD was rec-
ognized. Phosphatase treatment of the immunoprecipitate
resulted in migration of the protein at the same molecular
mass as the phosphatase-treated protein from the SK70
immunoprecipitate (Fig. 5 A, lanes 5 and 2, respectively).
Based on mobility, the SK70 antibody under immunopre-
cipitation conditions appears to preferentially recognize
more highly phosphorylated forms of newt Rb as com-
pared with XZ56.
To compare the phosphorylation state of Rb in myo-
tubes maintained in low serum vs high serum, extracts
from highly purified myotubes (where the mononucleate
contamination was ,10%) were immunoprecipitated with
both SK70 and XZ56, to obtain all forms of Rb, and then
detected by Western blotting with SK70. The Rb that was
immunoprecipitated from extracts of myotubes maintained
in low serum migrated as a single band at 110 kD, indicat-
ing that none of the Rb was phosphorylated (Fig. 5 B,
lane 1). In contrast, z50% of Rb from myotubes main-
tained in high serum for 4 d had retarded mobility (Fig. 5
B, lane 2). At this time, 25–50% of myotubes are expected
to be in S phase. This profile was identical to the profile of
Rb that was immunoprecipitated from proliferating mono-
nucleate cells on which the antibodies were characterized
(Fig. 5 B, lane 3), and, as with the mononucleate cells,
phosphatase treatment of the immunoprecipitate caused
the Rb to migrate as a single band (data not shown). De-
tection of rabbit IgG confirmed that equivalent amounts
of SK70 were immunoprecipitated in each of the samples
(data not shown). Thus, like other vertebrate cells that un-
dergo a transition from the G0 or resting state to a prolifer-
ating state, the Rb in myotubes maintained in low serum is
solely in the nonphosphorylated form but becomes phos-
phorylated after stimulation by serum to enter S phase.
Discussion
Urodele amphibians have the remarkable ability among
adult vertebrates to regenerate much of the body plan in-
cluding the limbs, tail, and jaws, as well as ocular tissues
such as the lens. Regeneration proceeds by the local rever-
sal of differentiation of adult tissues to provide the prolif-
erating mesenchymal or epithelial progenitor cells of the
regenerate (Brockes, 1994; Okada, 1991; Wallace, 1981).
After removal of the lens, pigmented epithelial cells of the
dorsal iris lose their pigment and proliferate before trans-
differentiating into lens, a transition that can be repro-
duced in clonal cell culture (Eguchi et al., 1974; Okada,
1991). In limb regeneration, the blastemal progenitor cells
arise by dedifferentiation of mesenchymal tissues at the
amputation plane (Hay, 1959; Steen, 1968; Namenwirth,
1974; Lo et al., 1993). It is unclear to what extent urodele
cells are intrinsically different from those of other verte-
brates, and to what extent they encounter distinct signals
that evoke reversal.
Here we have shown that newt myotubes are different
from their mammalian counterparts. In culture, newt limb
cells withdraw from the cell cycle in low serum medium
and form myotubes, which are refractory to growth fac-
tors, but respond to elevated serum by entering S phase.
This response is striking because although it is known that
nuclei within mammalian myotubes are capable of synthe-
sizing DNA in response to the expression of certain viral
oncogenes (Endo and Nadal-Ginard, 1989; Iujvidin et al.,
1990; Crescenzi et al., 1995), deletion of the Rb gene
(Schneider et al., 1994), or infection by the parasitic nema-
tode Trichinella spiralis (Jasmer, 1993), this is the first dem-
onstration in which multinucleate myofibers undergo S phase
in response to serum stimulation without the need for di-
rect manipulation of internal cellular components. Fur-
thermore, it is significant that not only do these newt myo-
tubes enter S phase in response to serum, they do so
without apparent trauma or evoking apoptosis. This is in
contrast with the degeneration seen when SV-40 large T
induces reentry in mammalian myotubes (Endo and
Nadal-Ginard, 1989; Iujvidin et al., 1990).
It seems likely that the reentry response of newt myo-
tubes underlies their ability to dedifferentiate during re-
generation. Histological examination of muscle fibers in
early regenerating limbs labeled with [3H]thymidine has
identified some fibers containing labeled nuclei (Hay, 1959).
Although these experiments could not definitively distin-
guish between cells that had newly fused to form fibers as
opposed to nuclei returning to the cell cycle within fibers,
they are consistent with entry into S phase being a very
early step in endogenous dedifferentiation.
If induction of S phase is the initial step in muscle dedif-
ferentiation during limb regeneration, then, in vivo, these
muscle cells must go on to resolve into mononucleate cells.
Indeed, Lo et al. (1993) showed that the same myotubes as
those used here do form mononucleate cells when im-
planted into the regenerating limb. The execution of mito-
sis with attendant cytokinesis seems a likely means by
which the nuclei in the syncytial myotube could resolve
Table IV. Expression of D34 Rb Inhibits Cell Cycle Reentry
Rb type
Percentage of
inhibition n
Number of
injected nuclei
D34 88 4 612
Wild-type 30 4 1,447
Plates of myotubes were microinjected with either D34 Rb or wild-type Rb as a con-
trol. The myotubes were stimulated with serum, and entry into S phase, as assayed by
[3H]thymidine, was measured as described. To calculate percentage of inhibition, the
fraction of Rb-immunopositive cells that were positive for [3H]thymidine was counted
(denoted a), and the fraction of nuclei in uninjected myotubes on the same plate that
were positive for [3H]thymidine was counted separately (denoted b). Percentage of inhi-
bition 5 100 2 (100 3 a/b). For each plate, at least 1,000 nuclei from uninjected myo-
tubes were counted.
n, number of experiments; Number of injected nuclei, total number of Rb-immuno-
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into individual cells, although other mechanisms that do
not rely on reentering the cell cycle are possible. It is most
likely that in culture an additional signal is required to
overcome the G2-M arrest, and this is not present in FCS.
It is also possible that a separate signal inducing further re-
versal of differentiation is required before the G2-M block
can be relieved. A third possibility is that the configuration
that the myotubes assume in culture, in which the nuclei
cluster in the center rather than disperse along the fiber, is
not conducive to resolution into mononucleate cells.
What is the molecular basis of plasticity in the newt myo-
tubes? Experiments in mammalian myotubes where elim-
ination of Rb function, either by genomic deletion or inac-
tivation by viral proteins, results in S-phase entry by
myotube nuclei indicate that differences in regulation of
Rb may underlie the ability of newt myotubes to retain a
serum response after differentiation. In normal cycling
cells, phosphorylation of Rb appears to be the predomi-
nant means of inactivating Rb function at the G1 to S tran-
sition. In differentiated cells such as mammalian muscle,
cell cycle arrest is not relieved by serum stimulation pre-
sumably because the kinases such as CDK4 that normally
phosphorylate Rb in response to mitogens are inhibited
from doing so by CDIs present at high levels in these cells
(Guan et al., 1994; Parker et al., 1995). In Rb2/2 mouse
myoblasts, the Rb-like protein p107 appears to substitute
for Rb to allow exit from the cell cycle and differentiation,
but, unlike Rb, expression of p107 in the myotubes is
downregulated in response to serum, thus bypassing the
need for phosphorylation (Schneider et al., 1994). Alterna-
tively, when viral oncogenes are expressed in a myotube,
they bind and sequester Rb (Gu et al., 1993), thus driving
the cells into S phase.
The situation in the newt cells is rather different. We
have shown that newt myotubes express Rb, which is
phosphorylated upon cell cycle reentry. Furthermore, ex-
pression of the CDI p16 as well as expression of a mutant
Rb lacking all CDK consensus phosphorylation sites in-
hibits the serum response, indicating that phosphorylation
of Rb is a critical step in cell cycle reentry in these cells.
The dramatic inhibitory effect of p16 expression is consis-
tent with previous work indicating that high levels of p16
effectively inhibit the ability of cyclin D to bind cdk4 and
cdk6 both in vivo and in vitro (Xiong et al., 1993; Parry et
al., 1995). In this case, the complete inhibition of kinase
should result in none of the endogenous Rb becoming
phosphorylated by CDK4/6. In contrast, when the D34 Rb
mutant is expressed, the endogenous Rb is presumably
still subjected to mitogen-stimulated phosphorylation.
This competition between the mutant and the endogenous
Rb for binding to factors such as E2F may explain the in-
complete inhibition seen in the D34 Rb expression experi-
ments. 
It appears that in newt myotubes serum stimulation in-
duces S phase through activation of a cdk4/6-cyclin D or
related kinase that phosphorylates Rb. The simplest model
would posit that p16 or other CDIs are either not pro-
duced in the urodele cells, or are downregulated or inacti-
vated by the serum pathway. Of course, we do not know if
the effect is direct, or if other factors might be involved be-
tween serum stimulation and Rb phosphorylation. The
newt myotubes illustrate nonetheless that irreversible in-
activation of the Rb phosphorylation pathway is not a pre-
requisite of muscle differentiation.
It will be of interest to identify the extracellular factors
that regulate S-phase entry in the newt myotubes. The
present results distinguish two classes of factors—a stimu-
latory soluble activity that is present in serum, and a domi-
nant inhibitory factor on the surface of other cells that re-
sults in contact inhibition. These two contrasting activities
may explain how specificity of the response is achieved in
vivo. In general, newt muscle must be as firmly locked in
the differentiated state as its mammalian counterpart, with
dedifferentiation only being triggered under the special
circumstances of amputation. In this context, it is perhaps
not surprising that the reentry response is not stimulated
by standard growth factors and that this aspect of the post-
mitotic arrest is intact. It is an attractive hypothesis that
amputation relieves the inhibition of cell–cell contact, thus
allowing muscle fibers and other differentiated cells at the
amputation plane to respond locally to soluble serum fac-
tors.
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